Aurgalys Team
Selected Customers
Home
Interim Management
Quantum Genomics [ALQGC]
Corporate Finance
Management Assistance
Due Diligence
Interim Management
Investor Assistance
Onxeo [ONXEO]
Diaxonhit [ALEHT]
 

August 24th, 2015: Performance of French Life Sciences and Healthcare Smallcaps, Aurgalys celebrates 2-year anniversary of Alys Indices!

août 24, 2015

Paris-Evry, France, August 24th, 2015 – Aurgalys, a global provider for life sciences and healthcare companies through corporate finance, business development and interim management services, issued its monthly publication of its indices measuring the performance of French, Life Sciences and Healthcare smallcaps.

Alys indices, measuring the performance of French biotech/ medtech smallcaps, were created 2 years ago. Since their inception (July 18th, 2013), the number of French smallcaps has increased from 37 to 63, and the total market capitalization has tripled (from €3.97B to €11.85B).

You can download our report on the following link:

 

Comments are closed.